REYON PHARMACEUTICAL CO., LTD Logo

REYON PHARMACEUTICAL CO., LTD

Develops and manufactures APIs, generics, contrast agents, and biopharmaceuticals.

102460 | KO

Overview

Corporate Details

ISIN(s):
KR7102460003
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로 620 에이동 12층 (대치동, 미래에셋타워), 강남구

Description

REYON PHARMACEUTICAL CO., LTD. is a research-driven company engaged in the development and manufacturing of chemical and biopharmaceutical products. Its primary business areas encompass the production of Active Pharmaceutical Ingredients (APIs), a diverse portfolio of generic medicines, and contrast agents. The company leverages advanced synthesis know-how to supply high-value APIs to domestic and international partners. A key strategic focus is the development of next-generation biopharmaceuticals, including gene therapies for conditions like wet age-related macular degeneration and NK cell therapies for solid cancers. Reyon is also expanding its capabilities to offer contract development and manufacturing (CDMO) services for complex biologic drugs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
반기보고서 (2025.06)
Korean 2.5 MB
2025-08-01 00:00
[기재정정]사업보고서 (2024.12)
Korean 1.9 MB
2025-07-25 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 12.2 KB
2025-07-09 00:00
주식등의대량보유상황보고서(약식)
Korean 92.2 KB
2025-06-02 00:00
[기재정정]분기보고서 (2025.03)
Korean 1.8 MB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-25 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 10.9 KB
2025-03-28 00:00
정기주주총회결과
Korean 24.3 KB
2025-03-24 00:00
[기재정정]사업보고서 (2024.12)
Korean 2.1 MB
2025-03-20 00:00
감사보고서제출
Korean 20.0 KB
2025-03-20 00:00
사업보고서 (2024.12)
Korean 629.3 KB
2025-03-14 00:00
[기재정정]주주총회소집결의
Korean 14.8 KB
2025-03-14 00:00
[기재정정]주주총회소집공고
Korean 1.1 MB
2025-03-14 00:00
[기재정정]의결권대리행사권유참고서류
Korean 1.0 MB
2025-03-13 00:00
주주총회소집결의
Korean 10.9 KB

Automate Your Workflow. Get a real-time feed of all REYON PHARMACEUTICAL CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REYON PHARMACEUTICAL CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for REYON PHARMACEUTICAL CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.